Logotype for Akoya Biosciences Inc

Akoya Biosciences (AKYA) investor relations material

Akoya Biosciences Status Update summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Akoya Biosciences Inc
Status Update summary26 Jun, 2025

AI-driven spatial profiling and clinical application

  • AI-powered analysis of trillions of immune cell data points identified key predictors of cancer recurrence risk, focusing on spatial distribution and single-cell resolution.

  • Developed an AI strategy to filter massive datasets into a few clinically relevant biomarkers, enabling explainable and visualizable predictions at the single-cell level.

  • Introduced the concept of H&E 2.0, leveraging AI and cloud-based tools to enhance traditional pathology and streamline clinical trial recruitment.

  • AI-enabled virtual staining and immune scoring systems outperformed traditional prognostic factors in predicting liver cancer recurrence.

  • Human expertise remains integral in AI decision-making, ensuring clinical relevance and safety.

Key research findings and validation

  • Identified a five-gene immune signature, primarily involving NK cells, that accurately stratifies liver cancer patients by recurrence risk.

  • Immune scoring system based on these markers achieved an accuracy (AUC) of 0.82, surpassing existing clinical predictors.

  • Ex vivo and in vivo experiments confirmed the mechanistic role of NK cells and their interaction with CD8 T cells in tumor control.

  • High immune scores correlated with better response to immunotherapy, converting high-risk patients to favorable outcomes.

  • Spatial proteomics and mass spectrometry approaches revealed additional protein markers, including unannotated "dark proteins."

Future directions and broader impact

  • Ongoing work aims to automate image quantification and reporting for multiplexed assays, making clinical translation more efficient.

  • Efforts are underway to generalize the AI-driven scoring system for broader clinical and global health applications, including resource-limited settings.

  • The team is advancing H&E 2.0 and exploring further improvements, such as cloud-based platforms and new biomarker panels.

  • Emphasis on rigorous validation across technologies and settings to ensure findings are robust and biologically meaningful.

  • Encouragement for early-career scientists to persist, collaborate, and maintain integrity in research.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Akoya Biosciences Inc. offers spatial biology solutions used in the discovery and clinical research of diseases. The company provides imaging and analysis platforms that allow visualization of molecular markers in tissue samples. Its technologies support applications in immuno-oncology, pathology, and biomarker development. The company is headquartered in Marlborough, Massachusetts, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage